At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 22 enrolled
Drug / intervention
MDMA +1 moredrug
Likely dose
MDMA 1.5mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of MDMA on Responses to Affective Touch in Individuals With a Range of Autistic Traits
In Brief
A Early Phase 1 clinical trial evaluating MDMA and Placebo oral tablet for Autism Spectrum Disorder and Healthy. Completed, enrolled 22 participants across 1 site.
Detailed Summary
To study the effects of a psychostimulant on responses to affective touch in individuals with a range of autistic traits
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder, Healthy
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
2020202120222023202420252026
Enrollment StartAug 2019
First PostedAug 2019
Primary CompletionApr 2021
TodayJul 2026
First PostedAug 12, 2019
Enrollment StartAug 8, 2019
Primary CompletionApr 12, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 6.9 years ago
Interventions
MDMAdrug
Participants will be given 1.5mg/kg of MDMA
Placebo oral tabletdrug
Participants will be given a placebo capsule that will only contain lactose.